The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor

作者: Evgueni L. Saenko , Dorothea Scandella

DOI: 10.1074/JBC.272.29.18007

关键词:

摘要: A binding site for von Willebrand factor (vWf) was previously localized to the carboxyl terminus of C2 domain light chain (LCh) VIII (fVIII). The acidic region LCh, residues 1649-1689, also controls fVIII.vWf by an unknown mechanism. Although anti-acidic monoclonal antibodies prevent formation complex, direct involvement in this has not been demonstrated. By limited proteolysis LCh with Staphylococcus aureus V8 protease, we prepared 14- and 63-kDa fragments, which begin fVIII 1672 1795, respectively. Using surface plasmon resonance measure interactions, demonstrated that 14-kDa fragment binds vWf, but its affinity vWf (Kd 72 nM) 19-fold lower than LCh. This due altered conformation within fragment, since antibody similar All derivatives lacking (thrombin-cleaved recombinant C2, fragment) had greatly reduced affinities 564-660 compared 3.8 nM). In addition, these indicated apart from region, contains no other one C2. NMC-VIII/5 (epitope, 2170-2327) removal leads a conformational change is likely affect overlaps epitope NMC-VIII/5; therefore, appears be required maintain optimal site. Our results demonstrate are both directly involved forming high vWf.

参考文章(45)
A Leyte, M P Verbeet, T Brodniewicz-Proba, J A Van Mourik, K Mertens, The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII. Biochemical Journal. ,vol. 257, pp. 679- 683 ,(1989) , 10.1042/BJ2570679
M Nishino, JP Girma, C Rothschild, E Fressinaud, D Meyer, New variant of von Willebrand disease with defective binding to factor VIII. Blood. ,vol. 74, pp. 1591- 1599 ,(1989) , 10.1182/BLOOD.V74.5.1591.1591
AJ Vlot, SJ Koppelman, JC Meijers, C Dama, HM van den Berg, BN Bouma, JJ Sixma, GM Willems, Kinetics of Factor VIII-von Willebrand Factor Association Blood. ,vol. 87, pp. 1809- 1816 ,(1996) , 10.1182/BLOOD.V87.5.1809.1809
Sixma Jj, Bouma Bn, van Wijnen M, Koedam Ja, Stern Dm, Koppelman Sj, Nawroth Pp, von Willebrand factor as a regulator of intrinsic factor X activation. Journal of Laboratory and Clinical Medicine. ,vol. 123, pp. 585- 593 ,(1994)
AJ Vlot, SJ Koppelman, MH van den Berg, BN Bouma, JJ Sixma, The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor Blood. ,vol. 85, pp. 3150- 3157 ,(1995) , 10.1182/BLOOD.V85.11.3150.BLOODJOURNAL85113150
E.L. Saenko, M. Shima, K.J. Rajalakshmi, D. Scandella, A role for the C2 domain of factor VIII in binding to von Willebrand factor. Journal of Biological Chemistry. ,vol. 269, pp. 11601- 11605 ,(1994) , 10.1016/S0021-9258(19)78167-8
M. Nesheim, D.D. Pittman, A.R. Giles, D.N. Fass, J.H. Wang, D. Slonosky, R.J. Kaufman, The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. Journal of Biological Chemistry. ,vol. 266, pp. 17815- 17820 ,(1991) , 10.1016/S0021-9258(18)55200-5
P.J. Fay, P.J. Haidaris, T.M. Smudzin, Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. Journal of Biological Chemistry. ,vol. 266, pp. 8957- 8962 ,(1991) , 10.1016/S0021-9258(18)31537-0